Novo Nordisk· @novonordisk · X·· 8 小时前精选AI 评分62
AI 导读
诺和诺德公布一项针对肥胖伴肝脏脂肪过多成人的分析结果，接受治疗者中近九成在72周后肝脏脂肪水平恢复正常。治疗组肝脏脂肪含量从8.8%降至3.1%，相关结果在EASD 2026上公布。
推荐理由
诺和诺德公布肥胖伴肝脏脂肪过多人群的分析数据，可了解治疗72周后肝脏脂肪变化这一指标。
正文
#PRESS: In an analysis of adults with obesity and excess liver fat, nearly 9 in 10 who received treatment reached normal liver fat levels after 72 weeks. Measured liver fat fell from 8.8% to 3.1% in the treatment group.
Read more about the findings, presented at EASD 2026, in our press release: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=917205
来源：Novo Nordisk · x.com